Skip to content
2000
Volume 13, Issue 5
  • ISSN: 1570-193X
  • E-ISSN: 1875-6298

Abstract

The severe side effects of currently available cancer therapies led focus on a natural product, Curcumin, which has been traditionally used in Indian medicine from centuries. Curcumin has potential to act against various diseases including cancer. This review describes, Curcumin as safe, multitargeted lead molecule in anticancer drug development, and current advances in chemical modification of the basic structure to overcome its limitations. Curcumin showed various biological activities including cancer chemoprevention and anticancer in vitro, in vivo and Phase I clinical trials. The improved solubility and potency of synthesized monocarbonyl analogues (MACs) and diarylidenylpiperidone (DAPs) analogs motivate the researchers to harness its safe, multitargeted and immune system modulator properties.

Loading

Article metrics loading...

/content/journals/mroc/10.2174/1570193X13666160919142421
2016-10-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/mroc/10.2174/1570193X13666160919142421
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test